Public annual accounts

DOCTEUR HUSTINX SCPRL financials

Name: DOCTEUR HUSTINX SCPRL financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for DOCTEUR HUSTINX SCPRL, with comparable measures and links to available source documents.

Company overview

Registry number

0663810194

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 28, 2026

Financial evidence

Latest movements for DOCTEUR HUSTINX SCPRL

2025 versus 2024

Operating line: €219,785
EBITDA: €218,028
Total assets: €318,501
Equity: €20,460

EBITDA margin +99.2% · Equity ratio +6.4%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€219,785	€218,028	€318,501	€20,460	-
202431 Dec 2024	€179,297	€175,732	€304,722	€54,817	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report

Fiscal year

Gross margin

EBITDA

Total assets

Equity

Filing

202531 Dec 2025

€219,785

€218,028

€318,501

€20,460

202431 Dec 2024

€179,297

€175,732

€304,722

€54,817